Trial Profile
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2017
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 13 Aug 2011 New trial record